Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1994-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00169289PMID 7911558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat

  2005cited by this paper
• An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

  2004cited by this paper
• Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area.

  1993cited by this paper
• Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects.

  1993cited by this paper
• Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo.

  1993cited by this paper
• Contribution of an α1-adrenergic receptor subtype to the expression of the “ventral tegmental area syndrome”

  1992cited by this paper
• Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.

  1992cited by this paper
• Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.

  1991cited by this paper
• The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.

  1991cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.

  1990cited by this paper
• Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study

  1990cited by this paper
• Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage

  1990cited by this paper
• Clinical profile of remoxipride ‐ a combined analysis of a comparative double‐blind multicentre trial programme

  1990cited by this paper
• Kynurenate blocks the acute effects of haloperidol on midbrain dopamine neurons recorded in vivo

  1990cited by this paper
• On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.

  1989cited by this paper
• Efficacy, safety and tolerability of raclopride, a specific D2 receptor blocker, in acute schizophrenia: an open trial.

  1989cited by this paper
• Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo.

  1989cited by this paper
• Clonidine modulates dopamine cell firing in rat ventral tegmental area.

  1989cited by this paper
• Clonidine regularizes substantia nigra dopamine cell firing.

  1988cited by this paper
• Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.

  1988cited by this paper
• Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells.

  1988cited by this paper
• Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.

  1988cited by this paper
• Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

  1988cited by this paper
• Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry.

  1988cited by this paper
• New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations.

  1987cited by this paper
• Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.

  1987cited by this paper
• The rat brain in stereotaxic coordinates (2nd edn): by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213

  1987cited by this paper
• Dopamine receptors in brain and periphery.

  1987cited by this paper
• In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.

  1986cited by this paper
• Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

  1985cited by this paper
• Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis.

  1985cited by this paper
• Measurement of Neurotransmitter Release in vivo

  1985cited by this paper
• Anatomy of brain alpha1‐adrenergic receptors: In vitro autoradiography with [125I]‐heat

  1985cited by this paper
• The control of firing pattern in nigral dopamine neurons: burst firing

  1984cited by this paper
• Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

  1984cited by this paper
• Sulpiride in Tardive Dyskinesia

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons.

  1983cited by this paper
• Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

  1983cited by this paper
• Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat.

  1982cited by this paper
• Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization

  1981cited by this paper
• Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.

  1980cited by this paper
• Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.

  1980cited by this paper
• Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles.

  1979cited by this paper
• Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.

  1976cited by this paper
• Drugs, neurotransmitters, and schizophrenia.

  1974cited by this paper
• Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

  1973cited by this paper
• THE VARIABILITY OF CENTRAL NEURAL ACTIVITY IN A SENSORY SYSTEM, AND ITS IMPLICATIONS FOR THE CENTRAL REFLECTION OF SENSORY EVENTS.

  1963cited by this paper
• The Pharmacological Basis of Therapeutics

  1941cited by this paper

• 3D printing in oral and maxillofacial surgery: a nationwide survey among university and non-university hospitals and private practices in Germany

  2021cites this paper
• The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders

  2016cites this paper
• Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light–dark cycle

  2014cites this paper
• Assessments of the effects of nicotine and ketamine using tyrosine hydroxylase-green fluorescent protein transgenic zebrafish as biosensors.

  2013cites this paper
• Dopamine Receptors and the Treatment of Schizophrenia

  2010cites this paper
• Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms

  2009cites this paper
• What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum.

  2008cites this paper
• Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat

  2007cites this paper
• Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain.

  2007cites this paper
• Substrate‐mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of α‐synuclein

  2006cites this paper
• Atypical Antipsychotic Profile of NRA0045, a Novel Dopamine D4 receptor, 5-Hydroxytryptamine2A (5-HT2A) Receptor and α1 Adrenoceptor Antagonist

  2006cites this paper
• Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease

  2006cites this paper
• Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.

  2005cites this paper
• Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.

  2005cites this paper
• CHAPTER J3 – A Mouse Model for Multiple System Atrophy

  2005cites this paper
• Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine

  2004cites this paper
• Alpha‐1B adrenergic receptor knockout mice are protected against methamphetamine toxicity

  2003cites this paper
• Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.

  2003cites this paper
• The Atypical Antipsychotics Risperidone, Clozapine and Olanzapine Differ Regarding Their Sedative Potency in Rats

  2003cites this paper
• Preclinical effects of conventional and atypical antipsychotic drugs: defining the mechanisms of action

  2003cites this paper
• α-Adrenoceptor modulation hypothesis of antipsychotic atypicality

  2003cites this paper
• In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.

  2002cites this paper
• Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.

  2002cites this paper
• Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?

  2002cites this paper
• Effects of Typical and Atypical Antipsychotics and Receptor Selective Compounds on Acetylcholine Efflux in the Hippocampus of the Rat

  2002cites this paper
• Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats.

  2001cites this paper
• Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2‐adrenergic receptors (AR)s, serotonin (5‐HT)1A, 5‐HT1B, 5‐HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

  2000cites this paper
• Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

  2000cites this paper
• Enhancement of antipsychotic-like effects by combined treatment with the α1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats

  2000cites this paper
• Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

  2000cites this paper
• Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: role of 5-HT(2A) and alpha(1)-adrenoceptor antagonism.

  2000cites this paper
• Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.

  2000cites this paper
• In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats.

  1999cites this paper
• Central alpha1-adrenoceptors: their role in the modulation of attention and memory formation.

  1999cites this paper
• Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release.

  1998cites this paper
• Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.

  1998cites this paper
• BIMG 80, a Novel Potential Antipsychotic Drug: Evidence for Multireceptor Actions and Preferential Release of Dopamine in Prefrontal Cortex

  1997cites this paper
• Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum.

  1997cites this paper
• Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

  1996cites this paper
• Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

  1996cites this paper
• The role of mesoprefrontal dopamine neurons in stress.

  1996cites this paper
• Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens.

  1996cites this paper
• Preclinical Neurochemical and Electrophysiological Profile of 1192U90, A Potential Antipsychotic

  1996cites this paper
• Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].

  1995cites this paper
• Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine.

  1995cites this paper
• Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system

  1995cites this paper
• Reciprocal Autoreceptor and Heteroreceptor Control of Serotonergic, Dopaminergic and Noradrenergic on Behalf Of: British Association for Psychopharmacology

  year unknowncites this paper